CIM
IDXX icon

Cambria Investment Management’s Idexx Laboratories IDXX Stock Holding History

Cambria Investment Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$237K Buy
+450
New +$252K 0.01% 702
2026
Q1 		– Sell
-324
Closed -$219K – 685
2025
Q4 		$219K Buy
+324
New +$221K 0.01% 573

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

Cambria Investment Management's IDXX Position: Q2 2026 in Review

Cambria Investment Management opened a new position in Idexx Laboratories (IDXX) in Q2 2026: 450 shares worth $237K. The stake represents 0.01% of the portfolio and ranks #702 among its holdings. This is a return to the name: Cambria Investment Management previously reported a position in IDXX as recently as Q4 2025.

Cambria Investment Management first reported a position in IDXX in Q4 2025 and has held it in 2 quarters since. 1,296 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • Cambria Investment Management held 450 shares of Idexx Laboratories worth $237K as of Q2 2026.
  • Idexx Laboratories was a new Cambria Investment Management position in Q2 2026.
  • Idexx Laboratories made up 0.01% of Cambria Investment Management's portfolio in Q2 2026, its #702 holding.
  • Cambria Investment Management first reported a position in Idexx Laboratories in Q4 2025 and has held it in 2 quarters since.
  • 1,296 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on Cambria Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.